Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

24/07/2019 Port de Barcelona will have a rolling highway terminal 04/07/2019 New software to promote urban district heating and cooling networks 07/06/2019 Biodiversity in danger: Barcelona Synchrotron Park’s actions 28/05/2019 The UAB ranks first according to the CYD Foundation 23/05/2019 Alba: open day, workshop and last results 25/04/2019 The UAB Scientific and Technical Services: an opportunity for BSP’s companies
3 4 5 6 7 8 9 10 11 12 13